No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Jim Alwan Appointed President and CEO of Ventec Life Systems

Editor: What To Know

  • Ventec is building upon the award-winning innovation of the one-of-a-kind VOCSN Multi-Function Ventilator with revenue allocated for continued enhancements and the release of VOCSN Multi-View™ cellular, the first and only system to provide complete patient trending and monitoring for ventilator-dependent patients across multiple respiratory therapies.
  • Most recently Alwan served as the Senior Vice President and General Manager of the Hospital Respiratory Care Business at Philips Healthcare and as the Vice President, Innovation and Business Development at Becton Dickinson.
  • “By re-imagining respiratory therapy delivery in a uniquely integrated and connected solution, they have unlocked value that is now reshaping the respiratory care market and improving the lives of patients and caregivers.

Jim Alwan will also serve as a member of the Ventec Board of Directors. Jim Alwan brings to Ventec Life Systems extensive medical device leadership experience with more than 25 years developing and managing healthcare products.

Most recently Alwan served as the Senior Vice President and General Manager of the Hospital Respiratory Care Business at Philips Healthcare and as the Vice President, Innovation and Business Development at Becton Dickinson. He has delivered innovation and profitable growth in functional and operational roles in the medtech, telecommunications, and semiconductor sectors throughout startup, mid-cap, and large-cap global corporations.

“Jim Alwan brings a track record of industry accomplishment and effective leadership to Ventec,” said Ventec Life Systems Board of Directors Chairman Jim Hickey. “He has a unique blend of market knowledge, general management, and engineering skills. We are pleased that Jim has joined Ventec and look forward to significant company growth under his guidance.”

“I am delighted to join Ventec Life Systems to expand upon the unprecedented growth and remarkable progress of this team,” said Alwan. “By re-imagining respiratory therapy delivery in a uniquely integrated and connected solution, they have unlocked value that is now reshaping the respiratory care market and improving the lives of patients and caregivers.”

In 2020, Ventec increased manufacturing production 80x to lead the response to the critical care ventilator demand from the U.S. Federal Government, state governments, hospital systems, long term care facilities, and homecare (DME) companies.

Ventec is building upon the award-winning innovation of the one-of-a-kind VOCSN Multi-Function Ventilator with revenue allocated for continued enhancements and the release of VOCSN Multi-View™ cellular, the first and only system to provide complete patient trending and monitoring for ventilator-dependent patients across multiple respiratory therapies.

Jim Alwan holds BS, MS, and PhD degrees in Electrical Engineering from the University of Illinois in Champaign-Urbana.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy